View in EDS

Daidzein targets PI3K-Akt signaling and oxidative stress in glioblastoma: An Integrated pharmacological and in vitro study.

Saved in:

Bibliographic Details
Title:	Daidzein targets PI3K-Akt signaling and oxidative stress in glioblastoma: An Integrated pharmacological and in vitro study.
Authors:	Praisthy L J C; Department of Pharmacy, School of Chemical Sciences and Pharmacy, Central University of Rajasthan, Kishangarh, Rajasthan, India., Kushwah R; Department of Pharmacy, School of Chemical Sciences and Pharmacy, Central University of Rajasthan, Kishangarh, Rajasthan, India., Dubey S; Department of Pharmacy, School of Chemical Sciences and Pharmacy, Central University of Rajasthan, Kishangarh, Rajasthan, India., Labhade S; Dr. D.Y. Patil Institute of Pharmaceutical Sciences and Research, Pune 411018, Maharashtra, India., Karwa P; Dr. D.Y. Patil Institute of Pharmaceutical Sciences and Research, Pune 411018, Maharashtra, India., Jain S; Department of Pharmacy, School of Chemical Sciences and Pharmacy, Central University of Rajasthan, Kishangarh, Rajasthan, India. Electronic address: smitajain1994@gmail.com.
Source:	Brain research [Brain Res] 2025 Sep 15; Vol. 1863, pp. 149840. Date of Electronic Publication: 2025 Jul 16.
Publication Type:	Journal Article
Journal Info:	Publisher: Elsevier/North-Holland Biomedical Press Country of Publication: Netherlands NLM ID: 0045503 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-6240 (Electronic) Linking ISSN: 00068993 NLM ISO Abbreviation: Brain Res Subsets: MEDLINE
Database:	MEDLINE Ultimate

Description
ISSN:	1872-6240
DOI:	10.1016/j.brainres.2025.149840